Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer

909.7500 -1.25 (-0.14%)

NSE Sep 12, 2025 15:31 PM

45.69% Fall from 52W High

Volume: 182.2K

Strides Pharma Science Ltd.

23 Nov 2023

909.75

-0.14%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receives USFDA approval for Generic Suprep Bowel Prep Kit

More from Strides Pharma Science Ltd.

Recommended

Five Interesting Stocks Today - September 12, 2025

The Baseline | 12 Sep 2025, 04:39PM

Market closes higher, Hindustan Copper announces a Rs 2,000 crore capex

Trendlyne Marketwatch | 12 Sep 2025, 04:00PM

Earnings Call Transcript - Q1FY21 for Strides Pharma Science